US FDA Would See Another Austere Year With GOP Funding Bill, No PRV Reauthorization

 
• By Sarah Karlin-Smith
  
US Capitol building
The Republican funding bill released 8 March, if enacted, would once again give the FDA no boost in taxpayer funding. (Shutterstock)

More from Legislation

More from Rare Diseases